JAMES CROWLEY: Open Payments
NPI 1104077817 · PAYSON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 23 payments from 13 companies in 2025. Trend: 2023 $128 · 2024 $446 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
| Amgen Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Novo Nordisk Inc | 2 | $31 |
| Globus Medical, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
Products named: REXULTI, Kerendia, VOQUEZNA, EVENITY, CAPVAXIVE, Wegovy, Senza, TZIELD.
Industry payments across UT — which companies pay providers there.
